Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly
diagnosed and treated psychiatric disorders in childhood. Typically, children and …

Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …

Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common
psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD …

Background The Multimodal Treatment Study (MTA) began as a 14‐month randomized
clinical trial of behavioral and pharmacological treatments of 579 children (7–10 years of …

OBJECTIVES: We examined overall and incremental effectiveness of 2-dose varicella
vaccination in preventing community transmission of varicella among children aged 4 to 18 …

This Clinical Practice Guideline was revised. See https://doi. org/10.1542/peds. 2019-2528.
Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral …

Background Attention deficit hyperactivity disorder (ADHD) is among the most common
psychiatric disorders of childhood that persists into adulthood in the majority of cases. The …

Attention-deficit/hyperactivity disorder (ADHD) is defined by extreme levels of inattention–
disorganization and/or hyperactivity–impulsivity. In DSM-IV, the diagnostic criteria required …

Purpose This phase 3 clinical trial evaluated the efficacy and safety of viloxazine extended-
release capsules (VLX-ER) as a monotherapy for attention-deficit/hyperactivity disorder …

This practice parameter describes the assessment and treatment of children and
adolescents with attention-deficit/hyperactivity disorder (ADHD) based on the current …